Chief Investigator: Professor Leanne Dibbens Funding Amount: $ 100,000 Recipient: University of South Australia Overview: KCNT1 mutations cause one of the most severe forms of epilepsy in children, resulting in frequent drug resistant seizures and cognitive decline. Currently, there are no drugs available which specifically target the underlying cause of the seizures, the mutated KCNT1 … Continue reading Investigating FDA-approved drugs in an animal model of KCNT1-childhood epilepsy to identify potential new therapies for treating children